There is progress to report in the battle against Alzheimer's. While there is still no cure, new tests and new treatments are ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...

Older adults who took medications for high blood pressure, high cholesterol and diabetes had slower rates of cognitive ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk ( ...

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

A cancer drug that has already been approved by the US Food and Drug Administration (FDA) could also help people with ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the ...

People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using ...